ADVANCED OVARIAN CLEAR CELL ADENOCARCINOMA
Clinical trials for ADVANCED OVARIAN CLEAR CELL ADENOCARCINOMA explained in plain language.
Never miss a new study
Get alerted when new ADVANCED OVARIAN CLEAR CELL ADENOCARCINOMA trials appear
Sign up with your email to follow new studies for ADVANCED OVARIAN CLEAR CELL ADENOCARCINOMA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
New drug combo trial hopes to tame advanced cancers
Disease control Recruiting nowThis early-phase study tests a new drug called IACS-6274, given alone or with other medicines, in people with advanced solid tumors (like melanoma, ovarian, or head and neck cancers). The main goal is to find the safest dose and understand side effects. About 54 adults will take …
Matched conditions: ADVANCED OVARIAN CLEAR CELL ADENOCARCINOMA
Phase: PHASE1 • Sponsor: M.D. Anderson Cancer Center • Aim: Disease control
Last updated May 26, 2026 03:32 UTC
-
New vaccine aims to keep ovarian cancer at bay
Disease control Recruiting nowThis study tests a vaccine made from a patient's own white blood cells, designed to train the immune system to attack ovarian cancer cells. It is for people with advanced stage III or IV ovarian, fallopian tube, or primary peritoneal cancer. The goal is to see if the vaccine can …
Matched conditions: ADVANCED OVARIAN CLEAR CELL ADENOCARCINOMA
Phase: PHASE2 • Sponsor: Mayo Clinic • Aim: Disease control
Last updated May 11, 2026 20:41 UTC